PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8757959-2	1996	Here we show that L929 cells, expressing human APO-1 treated with agonistic antibodies (anti-APO-1), elicit an early and transient increase of S-adenosylhomocysteine (AdoHcy), a potent inhibitor of S-adenosylmethionine (AdoMet)-dependent methylation reactions.	S-Adenosylmethionine	198-218	Fas cell surface death receptor	Homo sapiens	47-52	
8757959-2	1996	Here we show that L929 cells, expressing human APO-1 treated with agonistic antibodies (anti-APO-1), elicit an early and transient increase of S-adenosylhomocysteine (AdoHcy), a potent inhibitor of S-adenosylmethionine (AdoMet)-dependent methylation reactions.	S-Adenosylmethionine	198-218	Fas cell surface death receptor	Homo sapiens	93-98	
8757959-2	1996	Here we show that L929 cells, expressing human APO-1 treated with agonistic antibodies (anti-APO-1), elicit an early and transient increase of S-adenosylhomocysteine (AdoHcy), a potent inhibitor of S-adenosylmethionine (AdoMet)-dependent methylation reactions.	S-Adenosylmethionine	220-226	Fas cell surface death receptor	Homo sapiens	47-52	
8757959-2	1996	Here we show that L929 cells, expressing human APO-1 treated with agonistic antibodies (anti-APO-1), elicit an early and transient increase of S-adenosylhomocysteine (AdoHcy), a potent inhibitor of S-adenosylmethionine (AdoMet)-dependent methylation reactions.	S-Adenosylmethionine	220-226	Fas cell surface death receptor	Homo sapiens	93-98